CYTOMED THERAPEUTICS LTD

GDTC · NASDAQ

Updated at 2026-11-16 21:36:43

$0.77-6.68%
Today's High
$0.84
Today’s Low
$0.76
CYTOMED THERAPEUTICS LTD (GDTC) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$0.80
Previous Close
$0.82
Volume
9.29K
Market Cap
$9.89M
P/E Ratio
--
EPS
$-0.29

Previous Day Range

$0.78$0.83

52-Week Range

$0.68$2.29

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
1 COMMONWEALTH LANE, SINGAPORE, SINGAPORE, 149544
Country
SG
Listing Date
2023-04-14
Fiscal Year End
December
Shares Outstanding
11.93M
CIK
0001873093

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company is headquartered in Singapore.

Financial Metrics

Revenue

2026-06-30

$157.28K

2026-03-31

$189.44K

2025-12-31

$168.5K

2025-09-30

$205.08K

Operating Expenses

2026-06-30

$1.63M

2026-03-31

$727.84K

2025-12-31

$1.8M

2025-09-30

$834.2K

Net Income

2026-06-30

-$1.77M

2026-03-31

-$885.22K

2025-12-31

-$1.73M

2025-09-30

-$868.34K

Net Profit Margin

2026-06-30

-1.12K%

2026-03-31

-467.28%

2025-12-31

-1.03K%

2025-09-30

-423.41%

Earnings Per Share

2026-06-30

--

2026-03-31

$0.00

2025-12-31

--

2025-09-30

$-0.19

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$1.54M

2026-03-31

-$783.52K

2025-12-31

-$1.51M

2025-09-30

-$986.63K

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.